Pharmacokinetics of novel atrial-selective antiarrhythmic agent vernakalant hydrochloride injection (RSD1235): influence of CYP2D6 expression and other factors - Mao, Z L; Wheeler, J J; Clohs, L; Beatch, G N; Keirns, J (J Clin Pharmacol, 2009)